I am not going to provide links back to the discussion on patents mainly involving jcurve and myself, but want to add that an "adverse" decision with respect to BTX1503 patentability may well, IMO, strengthen the BTX1503 FDA moat.
BOT - Anything but charting, page-1110
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 37.0¢ | $346.0K | 934.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 175934 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 167418 | 19 |
View Market Depth
| Last trade - 12.02pm 08/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |